cff-version: 1.2.0
abstract: "<p><em>Context </em>Radiofrequency ablation (RFA) is used as treatment for symptomatic thyroid nodules. However, factors influencing the volume reduction ratio (VRR) at 12 months are not yet fully understood. <em>Objective </em>The primary objective was evaluating the VRR at 12 months after RFA. Secondary objectives were the assessment of a learning curve and factors influencing the VRR at 12 months. <em>Design </em>This is a retrospective Dutch multi-center study. <em>Patients and intervention </em>Patients who underwent RFA for symptomatic thyroid nodules with available ultrasound follow-up were eligible for this study. <em>Main outcome measures </em>Ultrasound based VRR at 12 months and chronologically numbered RFA procedures. All patients’ baseline, ultrasound, treatment, and early follow-up factors were assessed for correlation with VRR at 12 months.&nbsp;</p>"
authors:
  - family-names: Van der Meeren
    given-names: M.
  - family-names: Boers
    given-names: Tim
    orcid: "https://orcid.org/0000-0002-5309-1941"
  - family-names: de Graaf
    given-names: P.
  - family-names: Duvivier
    given-names: K.
  - family-names: Dreijerink
    given-names: K.
  - family-names: Deden
    given-names: L.
  - family-names: Veendrick
    given-names: P.
  - family-names: Cernohorsky
    given-names: P.
  - family-names: Joosten
    given-names: F.
  - family-names: Savelberg
    given-names: B.
title: "Data underlying the publication:  Radiofrequency ablation for thyroid nodules (RATED study) - analysis of a learning curve and predictors of success"
keywords:
version: 1
identifiers:
  - type: doi
    value: 10.4121/dd66122a-77c2-4f05-a34a-6b5aed8223e0.v1
license: CC BY-NC 4.0
date-released: 2024-09-30